166 related articles for article (PubMed ID: 6252838)
1. Inhibition of the glycogen phosphorylase system during ochratoxicosis in chickens.
Warren MF; Hamilton PB
Appl Environ Microbiol; 1980 Sep; 40(3):522-5. PubMed ID: 6252838
[TBL] [Abstract][Full Text] [Related]
2. The behavior of hepatic phosphorylase b kinase, phosphorylase a and b after administration of glucagon to patients with glycogen storage disease type VIa.
Pieniazek D; Pronicka E; Pawłowska J
Horm Metab Res; 1986 Aug; 18(8):546-50. PubMed ID: 3093350
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of glycogenolysis by beta adrenergic agonists in skeletal muscle of mice with the phosphorylase kinase deficiency mutation (I strain).
Gross SR; Mayer SE; Longshore MA
J Pharmacol Exp Ther; 1976 Sep; 198(3):526-38. PubMed ID: 978457
[TBL] [Abstract][Full Text] [Related]
4. Involvement of cyclic AMP-dependent protein kinase on the phosphorylase kinase inhibition by glucose-6-phosphate in adipose tissue extracts.
Ruiz G; Sobrino F; Roca B; Goberna R
Horm Metab Res; 1986 Jan; 18(1):18-21. PubMed ID: 3005147
[TBL] [Abstract][Full Text] [Related]
5. Liver glycogenosis caused by a defective phosphorylase system: hemolysate analysis.
Baussan C; Moatti N; Odievre M; Lemonnier A
Pediatrics; 1981 Jan; 67(1):107-12. PubMed ID: 6787554
[TBL] [Abstract][Full Text] [Related]
6. Metabolic control of phosphorylase conversion in muscle. Effect of fasting and refeeding on the response of rat diaphragm glycogen phosphorylase, cyclic AMP Dependent protein kinase, and phosphorylase b kinase to adrenergic stimulation.
Hostmark AT; Gronnerod O; Horn RS
Horm Metab Res; 1976 Mar; 8(2):123-8. PubMed ID: 177346
[TBL] [Abstract][Full Text] [Related]
7. Modulation of basal hepatic glycogenolysis by nitric oxide.
Borgs M; Bollen M; Keppens S; Yap SH; Stalmans W; Vanstapel F
Hepatology; 1996 Jun; 23(6):1564-71. PubMed ID: 8675178
[TBL] [Abstract][Full Text] [Related]
8. Allosteric regulation of liver phosphorylase a: revisited under approximated physiological conditions.
Ercan N; Gannon MC; Nuttall FQ
Arch Biochem Biophys; 1996 Apr; 328(2):255-64. PubMed ID: 8645002
[TBL] [Abstract][Full Text] [Related]
9. Endogenous effectors of human liver glycogen phosphorylase modulate effects of indole-site inhibitors.
Ercan-Fang N; Taylor MR; Treadway JL; Levy CB; Genereux PE; Gibbs EM; Rath VL; Kwon Y; Gannon MC; Nuttall FQ
Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E366-72. PubMed ID: 15797986
[TBL] [Abstract][Full Text] [Related]
10. Molecular mode of inhibition of glycogenolysis in rat liver by the dihydropyridine derivative, BAY R3401: inhibition and inactivation of glycogen phosphorylase by an activated metabolite.
Bergans N; Stalmans W; Goldmann S; Vanstapel F
Diabetes; 2000 Sep; 49(9):1419-26. PubMed ID: 10969824
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the mechanism of isoproterenol-stimulated glycogenolysis in skeletal muscle of normal and phosphorylase kinase-deficient mice (I strain).
Gross SR; Bromwell K; Baanante IV
J Pharmacol Exp Ther; 1978 Jun; 205(3):732-42. PubMed ID: 207857
[TBL] [Abstract][Full Text] [Related]
12. The cyclin-dependent kinase (CDK) inhibitor flavopiridol inhibits glycogen phosphorylase.
Kaiser A; Nishi K; Gorin FA; Walsh DA; Bradbury EM; Schnier JB
Arch Biochem Biophys; 2001 Feb; 386(2):179-87. PubMed ID: 11368340
[TBL] [Abstract][Full Text] [Related]
13. Regulation by phosphorylase kinase of phosphoprotein phosphatase activity: simultaneous control of protein phosphorylation and dephosphorylation in skeletal muscle.
Gergely P; Bot G
Acta Biochim Biophys Acad Sci Hung; 1981; 16(3-4):163-78. PubMed ID: 6291302
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation/activation of phosphorylase b kinase by cAMP/Ca2(+)-independent, autophosphorylation-dependent protein kinase.
Yu JS; Yang SD
Biochem Biophys Res Commun; 1995 Feb; 207(1):140-7. PubMed ID: 7857257
[TBL] [Abstract][Full Text] [Related]
15. Glycogen phosphorylase activation by progesterone in liver.
Sancho MJ; Gomez-Muñoz A; Sanchez-Bueno A; Trueba M; Marino A
Exp Clin Endocrinol; 1988 Dec; 92(2):154-60. PubMed ID: 2854077
[TBL] [Abstract][Full Text] [Related]
16. The influence of sorbitol on the glycogenolytic pathway.
Bianchi A; Russo A
Physiol Chem Phys Med NMR; 1985; 17(4):401-5. PubMed ID: 3836420
[TBL] [Abstract][Full Text] [Related]
17. The catalytic activity of phosphorylase b in the liver. With a note on the assay in the glycogenolytic direction.
Stalmans W; Gevers G
Biochem J; 1981 Nov; 200(2):327-36. PubMed ID: 6803777
[TBL] [Abstract][Full Text] [Related]
18. Glycogen phosphorylase and its converter enzymes in haemolysates of normal human subjects and of patients with type VI glycogen-storage disease. A study of phosphorylase kinase deficiency.
Lederer B; Van Hoof F; Van den Berghe G; Hers H
Biochem J; 1975 Apr; 147(1):23-35. PubMed ID: 168880
[TBL] [Abstract][Full Text] [Related]
19. On the possible biological role of glycogen phosphorylase b in the liver [proceedings].
Gevers G; Stalmans W
Arch Int Physiol Biochim; 1980 Feb; 88(1):B30-B32. PubMed ID: 6155845
[No Abstract] [Full Text] [Related]
20. [Glycogen disease caused by disorders in the liver phosphorylase system].
Chibisov IV; Rozenfel'd EL; Chistova LV; Leont'ev AF
Vopr Med Khim; 1979; 25(1):47-9. PubMed ID: 284661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
